Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.

Pavo N, Raderer M, Goliasch G, Wurm R, Strunk G, Cho A, Novak JF, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider ST, Parschalk B, Scheithauer W, Pirker R, Kiesewetter B, Pacher R, Zielinski C, Hülsmann M.

Oncotarget. 2017 Apr 16;8(46):81250-81260. doi: 10.18632/oncotarget.17131. eCollection 2017 Oct 6.

2.

GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes.

Pavo N, Wurm R, Neuhold S, Adlbrecht C, Vila G, Strunk G, Clodi M, Resl M, Brath H, Prager R, Luger A, Pacher R, Hülsmann M.

Clin Chem. 2016 Dec;62(12):1612-1620. Epub 2016 Oct 18.

3.

Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.

Resl M, Clodi M, Vila G, Luger A, Neuhold S, Wurm R, Adlbrecht C, Strunk G, Fritzer-Szekeres M, Prager R, Pacher R, Hülsmann M.

Heart. 2016 Dec 15;102(24):1963-1968. doi: 10.1136/heartjnl-2015-308949. Epub 2016 Jul 25.

PMID:
27456261
4.

Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.

Wurm R, Resl M, Neuhold S, Prager R, Brath H, Francesconi C, Vila G, Strunk G, Clodi M, Luger A, Pacher R, Hülsmann M.

Heart. 2016 Oct 1;102(19):1544-51. doi: 10.1136/heartjnl-2015-308711. Epub 2016 May 25.

PMID:
27226327
5.

Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill Patients.

Schrutka L, Goliasch G, Meyer B, Wurm R, Koller L, Kriechbaumer L, Heinz G, Pacher R, Lang IM, Distelmaier K, Hülsmann M.

PLoS One. 2016 Mar 15;11(3):e0151706. doi: 10.1371/journal.pone.0151706. eCollection 2016.

6.

Outcome of conservative management vs. assist device implantation in patients with advanced refractory heart failure.

Adlbrecht C, Hülsmann M, Wurm R, Eskandary F, Neuhold S, Zuckermann A, Bojic A, Strunk G, Pacher R.

Eur J Clin Invest. 2016 Jan;46(1):34-41. doi: 10.1111/eci.12562. Epub 2015 Dec 23.

PMID:
26540663
7.

EXAMINE: targeting risk and treatment in diabetes.

Hülsmann M, Pacher R, Neuhold S.

Lancet. 2015 Oct 10;386(10002):1444-5. doi: 10.1016/S0140-6736(15)00407-9. No abstract available.

PMID:
26466043
8.

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.

Pavo N, Raderer M, Hülsmann M, Neuhold S, Adlbrecht C, Strunk G, Goliasch G, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider S, Parschalk B, Scheithauer W, Pirker R, Drach J, Zielinski C, Pacher R.

Heart. 2015 Dec;101(23):1874-80. doi: 10.1136/heartjnl-2015-307848. Epub 2015 Sep 28.

PMID:
26416836
9.

Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.

Koller L, Kleber ME, Brandenburg VM, Goliasch G, Richter B, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer TB, Delgado G, Tomaschitz A, Pilz S, Berger R, Mörtl D, Hülsmann M, Pacher R, März W, Niessner A.

Circ Heart Fail. 2015 Nov;8(6):1059-67. doi: 10.1161/CIRCHEARTFAILURE.115.002341. Epub 2015 Aug 13.

PMID:
26273098
10.

Association of nutritional risk index with metabolic biomarkers, appetite-regulatory hormones and inflammatory biomarkers and outcome in patients with chronic heart failure.

Gouya G, Voithofer P, Neuhold S, Storka A, Vila G, Pacher R, Wolzt M, Hülsmann M.

Int J Clin Pract. 2014 Nov;68(11):1293-300. doi: 10.1111/ijcp.12513. Epub 2014 Sep 2.

PMID:
25348381
11.

Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure.

Poelzl G, Altenberger J, Pacher R, Ebner CH, Wieser M, Winter A, Fruhwald F, Dornaus C, Ehmsen U, Reiter S, Steinacher R, Huelsmann M, Eder V, Boehmer A, Pilgersdorfer L, Ablasser K, Keroe D, Groebner H, Auer J, Jakl G, Hallas A, Ess M, Ulmer H; Austrian Working Group on Heart Failure.

Int J Cardiol. 2014 Jul 15;175(1):83-9. doi: 10.1016/j.ijcard.2014.04.255. Epub 2014 May 2.

PMID:
24857326
13.

Reply: cardiovascular prevention in diabetes mellitus: no magic remedies.

Pacher R.

J Am Coll Cardiol. 2014 May 20;63(19):2054-5. doi: 10.1016/j.jacc.2014.01.029. Epub 2014 Feb 19. No abstract available.

14.

Predictive power of the fractalkine receptor CX3CR1 on CD4 T cells in patients with chronic heart failure.

Koller L, Blum S, Korpak M, Richter B, Goliasch G, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A.

Int J Cardiol. 2014 Jan 15;171(1):96-7. doi: 10.1016/j.ijcard.2013.11.082. Epub 2013 Dec 4. No abstract available.

PMID:
24342397
15.

Association of endostatin with mortality in patients with chronic heart failure.

Gouya G, Siller-Matula JM, Fritzer-Szekeres M, Neuhold S, Storka A, Neuhofer LM, Clodi M, Hülsmann M, Pacher R, Wolzt M.

Eur J Clin Invest. 2014 Feb;44(2):125-35. doi: 10.1111/eci.12197. Epub 2013 Nov 28.

PMID:
24188329
16.

CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure.

Koller L, Richter B, Goliasch G, Blum S, Korpak M, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A.

Atherosclerosis. 2013 Oct;230(2):414-6. doi: 10.1016/j.atherosclerosis.2013.08.008. Epub 2013 Aug 19.

PMID:
24075776
17.

Estimated glomerular filtration rate and albuminuria: true predictors of cardiovascular events in obese patients with type 2 diabetes?

Resl M, Vila G, Kraxner R, Pacher R, Luger A, Hülsmann M, Neuhold S, Brath H, Prager R, Clodi M.

Wien Klin Wochenschr. 2013 Oct;125(19-20):629-33. doi: 10.1007/s00508-013-0422-3. Epub 2013 Sep 6.

PMID:
24061697
18.

Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.

Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, Panzenböck A, Jakowitsch J, Bangert C, Laimer D, Schreiber C, Karakus G, Hülsmann M, Pacher R, Lang IM, Maurer G, Bonderman D.

Circ Cardiovasc Imaging. 2013 Nov;6(6):1056-65. doi: 10.1161/CIRCIMAGING.113.000633. Epub 2013 Sep 13.

PMID:
24036385
19.

PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.

Huelsmann M, Neuhold S, Resl M, Strunk G, Brath H, Francesconi C, Adlbrecht C, Prager R, Luger A, Pacher R, Clodi M.

J Am Coll Cardiol. 2013 Oct 8;62(15):1365-72. doi: 10.1016/j.jacc.2013.05.069. Epub 2013 Jun 27.

20.

Prognostic utility of the Seattle Heart Failure Score and amino terminal pro B-type natriuretic peptide in varying stages of systolic heart failure.

Adlbrecht C, Hülsmann M, Neuhold S, Strunk G, Pacher R.

J Heart Lung Transplant. 2013 May;32(5):533-8. doi: 10.1016/j.healun.2013.01.1048. Epub 2013 Feb 28.

PMID:
23453573
21.

Renal function in heart failure: a disparity between estimating function and predicting mortality risk.

Plischke M, Neuhold S, Kohl M, Heinze G, Sunder-Plassmann G, Pacher R, Hülsmann M.

Eur J Heart Fail. 2013 Jul;15(7):763-70. doi: 10.1093/eurjhf/hft022. Epub 2013 Feb 20.

22.

Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study.

Neuhold S, Huelsmann M, Pernicka E, Graf A, Bonderman D, Adlbrecht C, Binder T, Maurer G, Pacher R, Mascherbauer J.

Eur Heart J. 2013 Mar;34(11):844-52. doi: 10.1093/eurheartj/ehs465. Epub 2013 Jan 18.

PMID:
23335604
23.

A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, Mörtl D, Maurer G, Pacher R, Huber K, Wojta J, Hülsmann M, Niessner A.

Int J Cardiol. 2013 Sep 30;168(2):1251-7. doi: 10.1016/j.ijcard.2012.11.052. Epub 2012 Dec 4.

PMID:
23218577
24.

Fractalkine is an independent predictor of mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mörtl D, Maurer G, Huber K, Pacher R, Wojta J, Hülsmann M, Niessner A.

Thromb Haemost. 2012 Dec;108(6):1220-7. doi: 10.1160/TH12-03-0195. Epub 2012 Sep 26.

PMID:
23014777
25.

Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure.

Plischke M, Neuhold S, Adlbrecht C, Bielesz B, Shayganfar S, Bieglmayer C, Szekeres T, Hörl WH, Strunk G, Vavken P, Pacher R, Hülsmann M.

Eur J Clin Invest. 2012 Jun;42(6):649-56. doi: 10.1111/j.1365-2362.2011.02631.x. Epub 2011 Dec 13.

PMID:
22150123
26.

Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.

Resl M, Clodi M, Neuhold S, Kromoser H, Riedl M, Vila G, Prager R, Pacher R, Strunk G, Luger A, Hülsmann M.

Diabet Med. 2012 Jun;29(6):721-5. doi: 10.1111/j.1464-5491.2011.03515.x.

PMID:
22050532
27.

A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus.

Clodi M, Resl M, Neuhold S, Hülsmann M, Vila G, Elhenicky M, Strunk G, Abrahamian H, Prager R, Luger A, Pacher R.

Eur J Prev Cardiol. 2012 Oct;19(5):944-51. doi: 10.1177/1741826711420015. Epub 2011 Aug 19.

PMID:
21856715
28.

Benefit of specialized clinics for the treatment of patients with heart failure.

Gouya G, Hammer A, Elhenicky M, Neuhold S, Wolzt M, Hülsmann M, Pacher R.

Eur J Intern Med. 2011 Aug;22(4):428-31. doi: 10.1016/j.ejim.2011.02.016. Epub 2011 Mar 29.

PMID:
21767764
29.

Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus.

Neuhold S, Resl M, Huelsmann M, Strunk G, Adlbrecht C, Rath C, Prager R, Luger A, Clodi M, Pacher R.

Eur J Clin Invest. 2011 Dec;41(12):1292-8. doi: 10.1111/j.1365-2362.2011.02539.x. Epub 2011 May 25.

PMID:
21615391
30.

[Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry].

Fruhwald FM, Ulmer H, Pacher R, Pölzl G, Dornaus C, Wieser M, Ebner C, Reiter S, Kaltenbach L, Altenberger J; Arbeitsgruppe Herzinsuffizienz der Österreichischen Kardiologischen Gesellschaft.

Wien Klin Wochenschr. 2011 Jun;123(11-12):378-83. doi: 10.1007/s00508-011-1591-6. Epub 2011 May 30. German.

PMID:
21614457
31.

Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.

Rychli K, Richter B, Hohensinner PJ, Kariem Mahdy A, Neuhold S, Zorn G, Berger R, Mörtl D, Huber K, Pacher R, Wojta J, Niessner A, Hülsmann M.

Heart. 2011 Jul;97(14):1158-63. doi: 10.1136/hrt.2010.220228. Epub 2011 May 14.

PMID:
21572126
32.

NT-proBNP and cardiac events in older diabetic patients.

Resl M, Neuhold S, Riedl M, Abrahamian H, Strunk G, Prager R, Clodi M, Hülsmann M, Luger A, Pacher R.

Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):399-405. doi: 10.1177/1741826710389362. Epub 2011 Feb 22.

PMID:
21450658
33.

NT-proBNP as a means of triage for the risk of hospitalisation in primary care.

Adlbrecht C, Neuhold S, Hülsmann M, Strunk G, Ehmsen U, Scholten C, Maurer G, Pacher R.

Eur J Prev Cardiol. 2012 Feb;19(1):55-61. doi: 10.1177/1741826710391545. Epub 2011 Feb 18.

PMID:
21450621
34.

Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care.

Adlbrecht C, Huelsmann M, Berger R, Moertl D, Strunk G, Oesterle A, Ahmadi R, Szucs T, Pacher R.

Eur J Clin Invest. 2011 Mar;41(3):315-22. doi: 10.1111/j.1365-2362.2010.02412.x. Epub 2010 Nov 10.

PMID:
21070222
35.

Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure.

Richter B, Rychli K, Hohensinner PJ, Berger R, Mörtl D, Neuhold S, Zorn G, Huber K, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A.

Atherosclerosis. 2010 Dec;213(2):545-8. doi: 10.1016/j.atherosclerosis.2010.08.061. Epub 2010 Aug 19.

PMID:
20843516
36.

Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long-term outcome.

Adlbrecht C, Hülsmann M, Gwechenberger M, Graf S, Wiesbauer F, Strunk G, Khazen C, Brodnjak I, Neuhold S, Binder T, Maurer G, Pacher R.

Eur J Clin Invest. 2010 Aug;40(8):678-84. doi: 10.1111/j.1365-2362.2010.02311.x. Epub 2010 Jun 7.

PMID:
20546015
37.

Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure.

Rychli K, Niessner A, Hohensinner PJ, Mahdy Ali K, Kaun C, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Maurer G, Pacher R, Wojta J.

Chest. 2010 Sep;138(3):656-64. doi: 10.1378/chest.09-2739. Epub 2010 Apr 30.

PMID:
20435653
38.

N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.

Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R.

J Am Coll Cardiol. 2010 Feb 16;55(7):645-53. doi: 10.1016/j.jacc.2009.08.078.

39.

Macrophage-modulating cytokines predict adverse outcome in heart failure.

Hohensinner PJ, Rychli K, Zorn G, Hülsmann M, Berger R, Mörtl D, Richter B, Huber K, Wojta J, Pacher R, Niessner A.

Thromb Haemost. 2010 Feb;103(2):435-41. doi: 10.1160/TH09-06-0399. Epub 2010 Jan 13.

PMID:
20076846
40.

Prognostic value of emerging neurohormones in chronic heart failure during optimization of heart failure-specific therapy.

Neuhold S, Huelsmann M, Strunk G, Struck J, Adlbrecht C, Gouya G, Elhenicky M, Pacher R.

Clin Chem. 2010 Jan;56(1):121-6. doi: 10.1373/clinchem.2009.125856. Epub 2009 Nov 2.

41.

Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment.

Adlbrecht C, Hülsmann M, Gwechenberger M, Strunk G, Khazen C, Wiesbauer F, Elhenicky M, Neuhold S, Binder T, Maurer G, Lang IM, Pacher R.

Eur J Clin Invest. 2009 Dec;39(12):1073-81. doi: 10.1111/j.1365-2362.2009.02217.x. Epub 2009 Oct 15. Erratum in: Eur J Clin Invest. 2012 Feb;42(2):229. Adelbrecht, C [corrected to Adlbrecht, Christopher]..

PMID:
19843157
42.

Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes.

Maier C, Clodi M, Neuhold S, Resl M, Elhenicky M, Prager R, Moertl D, Strunk G, Luger A, Struck J, Pacher R, Hülsmann M.

Diabetes Care. 2009 Oct;32(10):1890-5. doi: 10.2337/dc08-2168. Epub 2009 Jun 29.

43.

Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.

Berger R, Shankar A, Fruhwald F, Fahrleitner-Pammer A, Freemantle N, Tavazzi L, Cleland JG, Pacher R.

Eur Heart J. 2009 Sep;30(17):2109-16. doi: 10.1093/eurheartj/ehp210. Epub 2009 Jun 2.

PMID:
19493864
44.

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.

Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.

J Am Coll Cardiol. 2009 May 12;53(19):1783-90. doi: 10.1016/j.jacc.2009.01.057.

45.

[Heart failure in diabetes].

Resl M, Hülsmann M, Pacher R, Clodi M.

Wien Med Wochenschr. 2009;159(5-6):134-40. doi: 10.1007/s10354-009-0645-0. Review. German.

PMID:
19343290
46.

B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure.

Moertl D, Berger R, Hammer A, Huelsmann M, Hutuleac R, Pacher R.

J Card Fail. 2009 Apr;15(3):233-40. doi: 10.1016/j.cardfail.2008.11.002. Epub 2008 Dec 18.

PMID:
19327625
47.

Prognostic value of apoptosis markers in advanced heart failure patients.

Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Wojta J, Pacher R.

Eur Heart J. 2009 Apr;30(7):789-96. doi: 10.1093/eurheartj/ehp004. Epub 2009 Feb 4.

PMID:
19196721
48.

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

Adlbrecht C, Hülsmann M, Strunk G, Berger R, Mörtl D, Struck J, Morgenthaler NG, Bergmann A, Jakowitsch J, Maurer G, Lang IM, Pacher R.

Eur J Heart Fail. 2009 Apr;11(4):361-6. doi: 10.1093/eurjhf/hfp004. Epub 2009 Feb 3.

49.

Echo Doppler parameters predict response to cardiac resynchronization therapy.

Wiesbauer F, Baytaroglu C, Azar D, Blessberger H, Goliasch G, Graf S, Mundigler G, Pacher R, Maurer G, Binder T.

Eur J Clin Invest. 2009 Jan;39(1):1-10. doi: 10.1111/j.1365-2362.2008.02042.x.

PMID:
19087125
50.

Interactions of glucose metabolism and chronic heart failure.

Clodi M, Resl M, Stelzeneder D, Pacini G, Tura A, Mörtl D, Struck J, Morgenthaler NG, Bergmann A, Riedl M, Anderwald-Stadler M, Luger A, Pacher R, Hülsmann M.

Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):99-106. doi: 10.1055/s-2008-1081211. Epub 2008 Sep 30.

PMID:
19085703

Supplemental Content

Loading ...
Support Center